Why the study?
Does pre-stroke low-dose aspirin improve functional outcomes and reduce mortality in ischemic stroke patients with distal medium middle cerebral artery occlusion undergoing mechanical thrombectomy?
Does pre-stroke low-dose aspirin improve functional outcomes and reduce mortality in ischemic stroke patients with distal medium middle cerebral artery occlusion undergoing mechanical thrombectomy?
Pre-stroke low-dose aspirin may be safe and associated with improved functional outcomes and reduced mortality in patients undergoing mechanical thrombectomy for distal medium middle cerebral artery occlusion.
Answers are grounded in this paper and cite their sources.
Observational association warrants no practice change; leaves open randomized confirmation in DMVO thrombectomy.
Pre-stroke low-dose aspirin was associated with improved functional outcomes and reduced mortality in patients with DMVO undergoing MT, without a significant increase in sICH. These findings suggest that low-dose aspirin may be safe and associated with more frequent excellent outcomes for this patient population. Further prospective studies are needed to validate these results and assess long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Salim et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: